Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) Survey.
Adult
Aged
Attitude of Health Personnel
COVID-19
Female
Genital Neoplasms, Female
/ surgery
Gynecologic Surgical Procedures
/ methods
Gynecology
Humans
Laparoscopy
/ methods
Laparotomy
/ methods
Male
Middle Aged
Minimally Invasive Surgical Procedures
/ methods
Practice Patterns, Physicians'
/ trends
Robotic Surgical Procedures
/ methods
SARS-CoV-2
Societies, Medical
Surgical Oncology
Surveys and Questionnaires
Turkey
COVID-19
Gynecologic oncology
Laparoscopy
Survey
Turkey
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Feb 2022
01 Feb 2022
Historique:
received:
27
10
2021
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
5
3
2022
Statut:
epublish
Résumé
To evaluate gynecologic oncologists' trends and attitudes towards the use of Minimally invasive surgery (MIS) in active period of the COVID-19 pandemic in Turkey. Online national survey sent to members of Turkish Endoscopy Platform consisting of six sections and 45 questions between the dates 1-15 June 2020 in Turkey to explore their surgical practice during the pandemic in three hospital types: Education and research hospital/university hospital, state hospital and private Hospital. Participants were gynecologic oncologists who are members of Turkish Endoscopy Platform. Fifty-eight percent of participants canceled all operations except for cancer surgeries and emergent operations. About a quarter of participants (28%) continued to operate laparoscopically and/or robotically. For the evaluation of the suspected adnexial mass (SAM) 64% used laparotomy and only 13 % operated by laparoscopy (L/S). For the management of low-risk early-stage endometrial cancer only fifth of the participants preferred to perform L/S. For endometrial cancer with high-intermediate risk factors more than half of participants preferred complete staging with laparotomy. For advanced stage ovarian cancer, one-fifth of the participants preferred to perform an explorative laparotomy, whilst 15 % preferred diagnostic laparoscopy to triage the patients for either NACT or cytoreductive surgery. On the contrary 41 % of participants chose to have cytology by paracentesis for neo-adjuvant chemotherapy (NACT). Gynecologic oncologists with >10 years L/S experience used MIS more for SAM. Furthermore, experienced surgeons used L/S more for endometrial cancer patients. In busy COVID hospitals, more participants preferred laparotomy over L/S. Use of MIS decreased during the pandemic in Turkey. More experienced surgeons continued to perform MIS. Surgical treatment was the preferred approach for SAM, early-stage endometrial cancer. However, NACT was more popular compared to radical surgery.
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate gynecologic oncologists' trends and attitudes towards the use of Minimally invasive surgery (MIS) in active period of the COVID-19 pandemic in Turkey.
METHODS
METHODS
Online national survey sent to members of Turkish Endoscopy Platform consisting of six sections and 45 questions between the dates 1-15 June 2020 in Turkey to explore their surgical practice during the pandemic in three hospital types: Education and research hospital/university hospital, state hospital and private Hospital. Participants were gynecologic oncologists who are members of Turkish Endoscopy Platform.
RESULTS
RESULTS
Fifty-eight percent of participants canceled all operations except for cancer surgeries and emergent operations. About a quarter of participants (28%) continued to operate laparoscopically and/or robotically. For the evaluation of the suspected adnexial mass (SAM) 64% used laparotomy and only 13 % operated by laparoscopy (L/S). For the management of low-risk early-stage endometrial cancer only fifth of the participants preferred to perform L/S. For endometrial cancer with high-intermediate risk factors more than half of participants preferred complete staging with laparotomy. For advanced stage ovarian cancer, one-fifth of the participants preferred to perform an explorative laparotomy, whilst 15 % preferred diagnostic laparoscopy to triage the patients for either NACT or cytoreductive surgery. On the contrary 41 % of participants chose to have cytology by paracentesis for neo-adjuvant chemotherapy (NACT). Gynecologic oncologists with >10 years L/S experience used MIS more for SAM. Furthermore, experienced surgeons used L/S more for endometrial cancer patients. In busy COVID hospitals, more participants preferred laparotomy over L/S.
CONCLUSION
CONCLUSIONS
Use of MIS decreased during the pandemic in Turkey. More experienced surgeons continued to perform MIS. Surgical treatment was the preferred approach for SAM, early-stage endometrial cancer. However, NACT was more popular compared to radical surgery.
Identifiants
pubmed: 35225470
doi: 10.31557/APJCP.2022.23.2.573
pmc: PMC9272609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
573-581Références
Int J Gynaecol Obstet. 2020 Oct;151(1):33-38
pubmed: 32623717
J Clin Oncol. 2009 Nov 10;27(32):5337-42
pubmed: 19805678
Surg Endosc. 2020 Aug;34(8):3298-3305
pubmed: 32458289
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
J Clin Oncol. 2009 Nov 10;27(32):5331-6
pubmed: 19805679
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101729
pubmed: 32247066
Turk J Med Sci. 2020 Apr 18;50(SI-1):489-494
pubmed: 32304192
J Am Coll Surg. 2020 Oct;231(4):490-496
pubmed: 32673759
J Trauma Acute Care Surg. 2020 Jun;88(6):715-718
pubmed: 32282750
Gynecol Oncol. 2020 Aug;158(2):256-261
pubmed: 32482336
Int J Gynecol Cancer. 2020 Sep;30(9):1424-1433
pubmed: 32576608
Int J Gynecol Cancer. 2020 Aug;30(8):1108-1112
pubmed: 32641394
J Oncol. 2019 Jul 29;2019:3415630
pubmed: 31467535
Br J Surg. 2020 Jun;107(7):785-787
pubmed: 32191340
Int J Gynecol Cancer. 2020 Aug;30(8):1101-1107
pubmed: 32513664
Ann Surg. 2020 Sep 1;272(3):e240-e242
pubmed: 33759843
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):579-584
pubmed: 32232423
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Gynecol Oncol. 2020 Aug;158(2):236-243
pubmed: 32532460
J Nucl Med. 2020 Sep;61(9):1278-1283
pubmed: 32709733
Br J Surg. 2020 Sep;107(10):1250-1261
pubmed: 32350857
Int J Gynecol Cancer. 2020 Jul;30(7):1005-1011
pubmed: 32474451